New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant

In a report released on June 25, from UBS maintained a Buy rating on InSilico Medicine Cayman TopCo, with a price target of HK$77.00. The compa...

Raccontata datipranks.com